Long-Term Assessment of Remyelinating Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 10, 2016

Primary Completion Date

January 23, 2017

Study Completion Date

January 23, 2017

Conditions
Acute Optic Neuritis
Interventions
DRUG

Placebo

Administered as specified in the treatment arm.

DRUG

BIIB033 100mg/Kg

Administered as specified in the treatment arm.

Trial Locations (23)

Unknown

Research Site, Sydney

Research Site, Parkville

Research Site, Bruges

Research Site, Ottawa

Research Site, Olomouc

Research Site, Prague

Research Site, Glostrup Municipality

Research Site, Bamberg

Research Site, Berlin

Research Site, Dresden

Research Site, Düsseldorf

Research Site, Tübingen

Research Site, Budapest

Research Site, Milan

Research Site, Barcelona

Research Site, Córdoba

Research Site, Murcia

Research Site, Seville

Research Site, Valencia

Research Site, Solna

Research Site, Birmingham

Research Site, Glasgow

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY